Clinical trial

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

NCT05748990

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-04-01

PhaseNA

Study timeline

Study start (actual)2023-04-01Date precision: day

Registry last updated2026-09-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Healthyunresolved

Interventions

Intranasal insulinDRUG

PlaceboDRUG

Sponsors & collaborators

Centre for Addiction and Mental Healthlead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05748990 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.